UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.528

Sortiert nach

Bioinformatics and breast cancer: what can high-throughput genomic approaches actually tell us?

Journal of Clinical Pathology, 2009-10, Vol.62 (10), p.879-885

Sims, A H

2009

Link zum Volltext

Verfügbarkeit prüfen

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

British journal of cancer, 2012-05, Vol.106 (11), p.1779-1789

2012

Link zum Volltext

Verfügbarkeit prüfen

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

British journal of cancer, 2010-07, Vol.103 (3), p.401-410

2010

Link zum Volltext

Verfügbarkeit prüfen

Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer

Breast cancer research and treatment, 2014-08, Vol.147 (1), p.211-219

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue

Endocrine-related cancer, 2006-06, Vol.13 (2), p.617-628

2006

Link zum Volltext

Verfügbarkeit prüfen

KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals

Oncogene, 2013-04, Vol.32 (14), p.1821-1830

2013

Link zum Volltext

Verfügbarkeit prüfen

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

BMC cancer, 2014-02, Vol.14 (1), p.119-119, Article 119

2014

Link zum Volltext

Verfügbarkeit prüfen

TPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer

International journal of radiation biology, 2007-01, Vol.83 (6), p.409-420

2007

Link zum Volltext

Verfügbarkeit prüfen

Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance

Cancer research (Chicago, Ill.), 2015-04, Vol.75 (7), p.1457-1469

2015

Link zum Volltext

Verfügbarkeit prüfen

Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment

Oncotarget, 2015-06, Vol.6 (16), p.14687-14699

2015

Link zum Volltext

Verfügbarkeit prüfen

ER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy

Annals of oncology, 2019-05, Vol.30, p.iii16-iii16

2019

Link zum Volltext

Verfügbarkeit prüfen

EVIDENCE FOR AN INCREASED RISK FOR HYPERTENSION WITH CENTRALLY LOCATED BODY FAT AND THE EFFECT OF RACE AND SEX ON THIS RISK

American journal of epidemiology, 1984-04, Vol.119 (4), p.526-540

1984

Link zum Volltext

Verfügbarkeit prüfen

Orthopedic Surgical Oncology for Bone Tumors: A Case Study Atlas

1st Edition 2022, 2021

Link zum Volltext

Verfügbarkeit prüfen

Are there persons who are obese, but metabolically healthy?

Metabolism, 2001-12, Vol.50 (12), p.1499-1504

Sims, Ethan A.H.

2001

Link zum Volltext

Verfügbarkeit prüfen

Cyclin D1, Id1 and EMT in breast cancer

BMC cancer, 2011-09, Vol.11 (1), p.417-417, Article 417

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-04-28: A potential role for IL6ST mediating endocrine resistance in breast cancer via interaction with the ER signaling pathway

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-04-28

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-11-13: On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-11-13

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-11-09: Not presented

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-11-09

2019

Link zum Volltext

Verfügbarkeit prüfen

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

The journal of clinical endocrinology and metabolism, 2001-03, Vol.86 (3), p.1020-1025

2001

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-04-03: Molecular characterisation of ER+ breast cancer dormancy and acquired resistance using a clinical model: Potential involvement of epigenetic regulation

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-04-03

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-11-03: Measurement of on-treatment proliferation biomarkers in nodal metastasis improves prediction of endocrine therapy response using the EA2CliN test

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-11-03

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-08-03: EA2Clin: A novel immunohistochemical prognostic and predictive test for patients with estrogen receptor-Positive breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P4-P4-08-03

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-04-27: Investigating the incidence of ESR1 gene amplification in breast cancers resistant to multiple endocrine agents

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-04-27

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-04-14: Tracking ESR1 mutation clonal evolution in breast cancer using in situ mutation detection

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-04-14

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-10-26: Predicting benefit from HER2-targeted therapies in patients with ER+/HER2+ breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-10-26

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.528

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.777)
Mit Volltextzugriff
(3.100)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.820)
Life Sciences & Biomedicine
(1.405)
Humans
(1.053)
Female
(629)
Male
(513)
Biological And Medical Sciences
(477)
Animals
(409)
Adult
(340)
Middle Aged
(302)
Medical Sciences
(264)
Physical Sciences
(245)
Technology
(245)
Fundamental And Applied Biological Sciences. Psychology
(236)
Aged
(206)
Social Sciences
(197)
Biochemistry & Molecular Biology
(157)
Mice
(153)
Exact Sciences And Technology
(151)
Adolescent
(132)
Oncology
(128)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(61)
American Journal Of Digestive Diseases
(49)
The Journal Of Biological Chemistry
(45)
Journal Of Orthopaedic Trauma
(41)
Plos One
(39)
The Lancet
(27)
The New England Journal Of Medicine
(27)
Science
(26)
British Medical Journal
(24)
Nature
(22)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Bioinformatics and breast cancer: what can high-throughput genomic approaches actually tell us?

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer

Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue

KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

TPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer

Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance

Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment

ER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy

EVIDENCE FOR AN INCREASED RISK FOR HYPERTENSION WITH CENTRALLY LOCATED BODY FAT AND THE EFFECT OF RACE AND SEX ON THIS RISK

Orthopedic Surgical Oncology for Bone Tumors: A Case Study Atlas

Are there persons who are obese, but metabolically healthy?

Cyclin D1, Id1 and EMT in breast cancer

Abstract P5-04-28: A potential role for IL6ST mediating endocrine resistance in breast cancer via interaction with the ER signaling pathway

Abstract P3-11-13: On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer

Abstract P3-11-09: Not presented

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

Abstract P5-04-03: Molecular characterisation of ER+ breast cancer dormancy and acquired resistance using a clinical model: Potential involvement of epigenetic regulation

Abstract P5-11-03: Measurement of on-treatment proliferation biomarkers in nodal metastasis improves prediction of endocrine therapy response using the EA2CliN test

Abstract P4-08-03: EA2Clin: A novel immunohistochemical prognostic and predictive test for patients with estrogen receptor-Positive breast cancer

Abstract P5-04-27: Investigating the incidence of ESR1 gene amplification in breast cancers resistant to multiple endocrine agents

Abstract P5-04-14: Tracking ESR1 mutation clonal evolution in breast cancer using in situ mutation detection

Abstract P3-10-26: Predicting benefit from HER2-targeted therapies in patients with ER+/HER2+ breast cancer

Suchergebnisse filtern